Brief: Genoway and Sigma-Aldrich Expand Their CRISPR/CAS9 Strategic Alliance

genOway SA

08/09/2022 13:48

Sept 8 (Reuters) - Genoway SA  ALGEN.PA :
    * SIGMA-ALDRICH AND GENOWAY EXPAND THEIR CRISPR/CAS9
STRATEGIC
ALLIANCE
    * NEW STRUCTURE TO 2018 STRATEGIC ALLIANCE IN THE
CRISPR/CAS9
FIELD
    * GENOWAY WILL CONTINUE LEADING THE COMMERCIALIZATION OF THE
SIGMA-ALDRICH CRISPR PATENT PORTFOLIO IN THE FIELD OF RODENT
ANIMALS
    * SIGMA-ALDRICH WILL LEAD THE COMMERCIALIZATION OF THE
SIGMA-ALDRICH CRISPR PATENT PORTFOLIO

Source text for Eikon:  ID:nCNWmdkS7a 
Further company coverage:  ALGEN.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))